Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Composition of plant telomeres.
Zellinger B, Riha K. Zellinger B, et al. Biochim Biophys Acta. 2007 May-Jun;1769(5-6):399-409. doi: 10.1016/j.bbaexp.2007.02.001. Epub 2007 Feb 17. Biochim Biophys Acta. 2007. PMID: 17383025 Review.
Chromosome end protection by blunt-ended telomeres.
Kazda A, Zellinger B, Rössler M, Derboven E, Kusenda B, Riha K. Kazda A, et al. Among authors: zellinger b. Genes Dev. 2012 Aug 1;26(15):1703-13. doi: 10.1101/gad.194944.112. Epub 2012 Jul 18. Genes Dev. 2012. PMID: 22810623 Free PMC article.
Hsa-miR-375/RASD1 Signaling May Predict Local Control in Early Breast Cancer.
Zellinger B, Bodenhofer U, Engländer IA, Kronberger C, Strasser P, Grambozov B, Fastner G, Stana M, Reitsamer R, Sotlar K, Sedlmayer F, Zehentmayr F. Zellinger B, et al. Genes (Basel). 2020 Nov 26;11(12):1404. doi: 10.3390/genes11121404. Genes (Basel). 2020. PMID: 33255991 Free PMC article.
Hsa-miR-375 is a predictor of local control in early stage breast cancer.
Zehentmayr F, Hauser-Kronberger C, Zellinger B, Hlubek F, Schuster C, Bodenhofer U, Fastner G, Deutschmann H, Steininger P, Reitsamer R, Fischer T, Sedlmayer F. Zehentmayr F, et al. Among authors: zellinger b. Clin Epigenetics. 2016 Mar 8;8:28. doi: 10.1186/s13148-016-0198-1. eCollection 2016. Clin Epigenetics. 2016. PMID: 26962366 Free PMC article.
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3.
Zellinger B, Bodenhofer U, Engländer IA, Kronberger C, Grambozov B, Ruznic E, Stana M, Karner J, Fastner G, Sotlar K, Sedlmayer F, Zehentmayr F. Zellinger B, et al. Breast Cancer. 2022 Mar;29(2):274-286. doi: 10.1007/s12282-021-01308-y. Epub 2021 Dec 5. Breast Cancer. 2022. PMID: 34865205 Free PMC article.
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC.
Grambozov B, Stana M, Kaiser B, Karner J, Gerum S, Ruznic E, Zellinger B, Moosbrugger R, Studnicka M, Fastner G, Sedlmayer F, Zehentmayr F. Grambozov B, et al. Among authors: zellinger b. Cancers (Basel). 2022 Jan 23;14(3):573. doi: 10.3390/cancers14030573. Cancers (Basel). 2022. PMID: 35158841 Free PMC article. Review.
Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III.
Stana M, Grambozov B, Gaisberger C, Karner J, Ruznic E, Berchtold J, Zellinger B, Moosbrugger R, Studnicka M, Fastner G, Sedlmayer F, Zehentmayr F. Stana M, et al. Among authors: zellinger b. Diagnostics (Basel). 2022 Apr 19;12(5):1027. doi: 10.3390/diagnostics12051027. Diagnostics (Basel). 2022. PMID: 35626183 Free PMC article.
18 results